Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM2 | P08172 | 2/20 | 0.64 |
| ▸ | CHRM5 | P08912 | 2/20 | 0.64 |
| ▸ | CHRM1 | P11229 | 2/20 | 0.64 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.40 |
| ▸ | THRB | P10828 | 1/20 | 0.40 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.40 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.40 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.40 |
| ▸ | BLM | P54132 | 1/20 | 0.39 |
| ▸ | MCOLN3 | Q8TDD5 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9009653 | 1.00 | CHRM2 (0.64) | CHRM2CHRM5CHRM1LMNACHRM4 | |
| SCHEMBL9009633 | 1.00 | CHRM2 (0.64) | CHRM2CHRM5CHRM1LMNACHRM4 | |
| SCHEMBL9625426 | 0.78 | CHRM2 (0.40) | CHRM2CHRM5CHRM1 | |
| SCHEMBL10389754 | 0.78 | CHRM2 (0.40) | CHRM2CHRM5CHRM1 | |
| Milameline SCHEMBL8730172 | 0.78 | CHRM2 (1.00) | CHRM2CHRM5CHRM1LMNACHRM4 | |
| Milameline SCHEMBL195143 | 0.78 | CHRM2 (1.00) | CHRM2CHRM5CHRM1LMNACHRM4 | |
| Milameline SCHEMBL8730187 | 0.77 | CHRM2 (0.97) | CHRM2CHRM5CHRM1LMNACHRM4 | |
| SCHEMBL10389007 | 0.77 | CHRM2 (0.46) | CHRM2CHRM5CHRM1LMNACHRM4 | |
| SCHEMBL10389008 | 0.77 | CHRM2 (0.46) | CHRM2CHRM5CHRM1LMNACHRM4 | |
| Milameline SCHEMBL5819625 | 0.77 | CHRM2 (0.97) | CHRM2CHRM5CHRM1LMNACHRM4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-4798841-A | COGNITION ACTIVATORS, ANALGESICS | WARNER-LAMBERT COMPANY (US) | 1989-01-17 | — | — | US | claimed |
| EP-0291673-A1 | Tetrahydropyridine oximes, a process for their preparation and use thereof as cholinergic agents | WARNER-LAMBERT COMPANY (US) | 1988-11-23 | — | — | EP | claimed |
| US-5532375-A | Process for preparing 1,2,5,6-tetrahydropyridin-3-carboxaldehyde oximes | ROUSSEL-UCLAF (FR) | 1996-07-02 | — | — | US | disclosed |
| US-5391754-A | Oximination a tetrahydropyridin-3-aldehyde, alkylation with a halides, salt formation | ROUSSEL UCLAF (FR) | 1995-02-21 | — | — | US | disclosed |
| US-5219872-A | Treating Alzheimer*s disease, memory disorders | ROUSSEL UCLAF (FR) | 1993-06-15 | — | — | US | disclosed |
| EP-0271798-B1 | O-SUBSTITUTED TETRAHYDROPYRIDINE OXIME CHOLINERGIC AGENTS | WARNER-LAMBERT COMPANY (US) | 1993-04-07 | — | — | EP | disclosed |
| US-4798841-A | COGNITION ACTIVATORS, ANALGESICS | WARNER-LAMBERT COMPANY (US) | 1989-01-17 | — | — | US | disclosed |
| US-4786648-A | ANALGESIC | WARNER-LAMBERT COMPANY (US) | 1988-11-22 | — | — | US | disclosed |
| EP-0271798-A2 | O-Substituted tetrahydropyridine oxime cholinergic agents | WARNER-LAMBERT COMPANY (US) | 1988-06-22 | — | — | EP | disclosed |